This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Refractive Errors, Myopia or Hypermetropia
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to evaluate worn AIR OPTIX® plus HYDRAGLYDE® (AOHG) lenses cleaned and disinfected with HYDRAGLYDE® containing lens solutions compared to each of the control habitual silicone hydrogel (SiHy) lenses cleaned and disinfected with habitual multi-purpose solution (MPS) for cholesterol uptake.

Provided treatments

  • Device: Lotrafilcon B contact lenses with added wetting agent
  • Device: Samfilcon A contact lenses
  • Device: POLYQUAD/ALDOX-preserved contact lens solution with added wetting agent
  • Device: Hydrogen peroxide-based contact lens solution with added wetting agent
  • Device: Senofilcon C contact lenses
  • Device: Senofilcon A contact lenses
  • Device: Comfilcon A contact lenses
  • Device: Habitual Multi-Purpose Solution (HMPS)
Tris trial is registered with FDA with number: NCT03026257. The sponsor of the trial is Alcon, a Novartis Company and it is looking for 323 volunteers for the current phase.
Official trial title:
Clinical Assessment of a Regimen of AIR OPTIX® Plus HYDRAGLYDE® Silicone Hydrogel Lenses and HYDRAGLYDE® Containing Lens Care Solutions